A Phase 4 interventional study of CURE-EX device in Onychomycosis, sponsored by MB Mazor Ltd.. Status unknown at 1 site in Israel. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2015-05-06.
Sponsored by MB Mazor Ltd. · Phase 4, Interventional, and Treatment
Open label study to evaluate the efficacy of CURE-EX device in the treatment of onychomycosis.
Each affected nail will be treated twice daily for 24-30 weeks. Efficacy will be evaluated by measuring the growth of healthy nail.
147 studies on the registry are indexed under Onychomycosis; 13 are open to participants now.
This study's planned enrollment of 50 is below the median of 56 across 134 interventional studies indexed under Onychomycosis.
Browse Onychomycosis studies →This is the only study on the registry with MB Mazor Ltd. as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
twice daily treatment with CURE-EX device for 24-30 weeks
Device: CURE-EX device
Treatment with CURE-EX device twice daily for 24-30 weeks.
Nail cure as measured by measured by length of healthy nail of at least 5 mm
Cure measured by length of healthy nail of at least 5 mm
Time frame: 24-30 weeks
Nail cure as measured by culture and smear
Nail culture and smear
Time frame: 24-30 weeks
This study is status unknown, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.